Search research articles

Karl W Patterson

3PUBLICATIONS

7CO-AUTHORS

Cancer geneticsEconometric and statistical methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Mar 13, 2026

The broad societal value of pembrolizumab for women's cancer in Canada.

Elizabeth Brook, Karl Patterson, Nishini Wijenayake

|Sep 17, 2025

Evaluating the broad societal value of pembrolizumab in women's cancer in Brazil.

Nishini Wijenayake, Daniel Ladino, Karl Patterson

|Mar 30, 2024

Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes.

Rose J Hart, Fareen Hassan, Sarah Alulis

Pageof 1

Frequent Collaborators

2 joint publications

Annabelle Davies

2 joint publications

Kate Young

1 joint publications

Mariana Rosim

1 joint publications

Elizabeth Brook

1 joint publications

Rose J Hart

1 joint publications

Sarah Alulis

1 joint publications

Dawn Lee

Frequent Collaborators

2 joint publications

Annabelle Davies

2 joint publications

Kate Young

1 joint publications

Mariana Rosim

1 joint publications

Elizabeth Brook

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos